22 Фев. 2015 г.
Камера 6 медика
O’Connor. Proof of concept for low-dose molecular breast imaging with a dual-head CZT gamma camera. The dual head technology identifies tumors in dense breast tissue where findings are inconclusive or even negative with film-based and digital mammography. In a proof-of-principle study involving 936 women with dense breast tissue, the combination of mammography and LumaGEM MBI was significantly more sensitive than mammography alone in detecting cancer (91% vs.
LumaGEM is a planar, dual head, fully solid state digital imaging system utilizing cadmium zinc telluride (CZT) technology. Dedicated Dual Head Gamma Imaging for Breast Cancer Screening in Women with Mammographically Dense Breasts. Comparison of Radiation Exposure and Associated Radiation-induced Cancer Risks from Mammography and Molecular Imaging of the Breast. The LumaGEM Molecular Breast Imaging (MBI) system is an effective adjunct to standard mammography. In particular, LumaGEM is a patient-friendly and cost-effective tool for detecting early-stage cancers in dense breast tissue.
Barlow, and Japanese general Tomoyuki Yamashita meet to accept the Japanese surrender at Kiangan, Northern Luzon, in the Philippines, World War II. L-R (front row): Hermann Goering (writing), Rudolf Hess, Joachim von Ribbentrop and Wilhelm Keitel, (back row) Karl Donitz, Erich Raeder, Baldur von Schirach, and Fritz Sauckel.
Our patented mounting mechanism allows the use of light breast compression for greater patient comfort during the exam.
LumaGEM is able to detect breast cancers as small as 5 mm that may be missed by mammography. The LumaGEM MBI system received FDA 510(k) clearance in 2011, and is installed in hospitals and breast imaging centers around the country. The technology measures and images the distribution of radionuclides by means of photon detection in order to aid in the evaluation of lesions in the breast tissue.
|
|